Dr. Abby Pulsipher Awarded NIAID Grant Funding
Congratulations to PI Abby Pulsipher (Molecular Pharmaceutics and Otolaryngology – Head & Neck Surgery) and her Co-Is, Justin Savage (GlycoMira Therapeutics), FokVun Chan (Echelon Biosciences), Jeremiah Alt, Kristine Smith, and Bryan McRae (Otolaryngology – Head & Neck Surgery), for receiving an R41 grant award from the National Institute of Allergy and Infectious Diseases! This Small Business Technology Transfer grant, “Development of a Diagnostic Test for Eosinophilic Chronic Rhinosinusitis,” represents a collaboration between GlycoMira Therapeutics and the University of Utah.
Their work will focus on optimizing and clinically validating a minimally invasive, rapid point-of-care test that can provide accurate diagnostic information to healthcare providers and patients with eosinophilic chronic rhinosinusitis, a disease with an under-recognized burden on patient quality of life, clinical resources, and the healthcare economy.
The investigators envision that this test might also have prognostic value to serve as an objective clinical tool for monitoring patient response to medical and surgical treatments.
